Neuroimaging

Drugs and the Future

Volumn , Issue , 2007, Pages 285-314

  Garavan, Hugh ^a   Lingford Hughes, Anne ^b   Jones, Terry ^c   Morris, Peter ^d   Rothwell, John ^e   Williams, Steve ^f  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

^f KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84880266575     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012370624-9/50012-8     Document Type: Chapter

References (144)

1. Abi-Dargham A., Krystal J.H., Anjilvel S., et al. Alterations of benzodiazepine receptors in type II alcoholic subjects measured with SPECT and [123I]iomazenil. Am J Psychiatry 1998, 155(11):1550-1555.
2. Alain C., et al. Neuropsychological evidence of error-monitoring deficits in patients with schizophrenia. Cereb Cortex 2002, 12:840-846.
3. Aron A.R., et al. Inhibition and the right inferior frontal cortex. Trends Cogn Sci 2004, 8:170-177.
4. Bartzokis G., et al. Abstinence from cocaine reduces high-risk responses on a gambling task. Neuropsychopharmacology 2000, 22:102-103.
5. Bechara A., et al. Emotion, decision making, and the orbitofrontal cortex. Cereb Cortex 2000, 10:295-307.
6. Bechara A., et al. Decision-making and addiction (part II): myopia for the future or hypersensitivity to reward?. Neuropsychologia 2002, 40:1690-1705.
7. 13C NMR for the assessment of human brain glucose metabolism in vivo. Biochemistry 1991, 30:6362-6366.
8. Boileau I., Assaad J.M., Pihl R.O., Benkelfat C., Leyton M., Diksic M., Tremblay R.E., Dagher A. Alcohol promotes dopamine release in the human nucleus accumbens. Synapse 2003, 49:226-231.
9. Bolla K.I., et al. Dose-related neurocognitive effects of marijuana use. Neurology 2002, 59:1337-1343.
10. Bolla K.I., et al. Orbitofrontal cortex dysfunction in abstinent cocaine abusers performing a decision-making task. Neuroimage 2003, 19:1085-1094.
11. Bolla K.I., et al. Prefrontal cortical dysfunction in abstinent cocaine abusers. J Neuropsychiatry Clin Neurosci 2004, 16:1-8.
12. Bolla K.I., et al. Neural substrates of faulty decision-making in abstinent marijuana users. Neuroimage 2005, 26:480-492.
13. Bonson K.R., et al. Neural systems and cue-induced cocaine craving. Neuropsychopharmacology 2002, 26:376-386.
14. Botvinick M.M., et al. Conflict monitoring and anterior cingulate cortex: an update. Trends Cogn Sci 2004, 8:539-546.
15. 2 by low-field thermal mixing. Chem Phys Lett 1993, 205(2-3):168-170.
16. Brody A.L., Mandelkern M.A., London E.D., Childress A.R., Lee G.S., Bota R.G., Ho M.L., Saxena S., Baxter L.R., Madsen D., Jarvik M.E. Brain metabolic changes during cigarette craving. Arch Gen Psychiatry 2002, 59:1162-1172.
17. Brody A.L., Olmstead R.E., London E.D., Farahi J., Meyer J.H., Grossman P., Lee G.S., Huang J., Hahn E.L., Mandelkern M.A. Smoking-induced ventral striatum dopamine release. Am J Psychiatry 2004, 161:1211-1218.
18. Brookes M.J., Gibson A.M., Hall S.D., Furlong P.L., Barnes G.R., Hillebrand A., Singh K.D., Holliday I.E., Francis S.T., Morris P.G. A general linear model for MEG beamformer imaging. Neuroimage 2004, 23(3):936-946.
19. Brookes M.J., Gibson A.M., Hall S.D., Furlong P.L., Barnes G.R., Hillebrand A., Singh K.D., Holliday I.E., Francis S.T., Morris P.G. GLM-Beamformer method demonstrates stationary field, alpha ERD and gamma ERS co-localisation with fMRI BOLD response in visual cortex. Neuroimage 2005, 26:302-308.
20. Buchert R., Thomasius R., Wilke F., Petersen K., Nebeling B., Obrocki J., Schulze O., Schmidt U., Clausen M. A voxelbased PET investigation of the long-term effects of 'Ecstasy' consumption on brain serotonin transporters. Am J Psychiatry 2004, 161:1181-1189.
21. Bunge S.A., et al. Prefrontal regions involved in keeping information in and out of mind. Brain 2001, 124:2074-2086.
22. Busemeyer J.R., Stout J.C. A contribution of cognitive decision models to clinical assessment: decomposing performance on the Bechara Gambling Task. Psychol Assess 2002, 14:2523-2562.
23. 13C] MRS and fMRI. Magn Reson Med 2001, 45:349-355.
24. 13C magnetic resonance spectroscopy. J Neurosci Res 2001, 66:737-746.
25. Childress A.R., Mozley P.D., McElgin W., Fitzgerald J., Reivich M., O'Brien C.P. Limbic activation during cue-induced cocaine craving. Am J Psychiatry 1999, 156(1):11-18.
26. Cohen J.D., et al. Anterior cingulate and prefrontal cortex: who's in control?. Nature Neuroscience 2000, 3:421-423.
27. Daglish M.R., Weinstein A., Malizia A.L., Wilson S., Melichar J.K., Britten S., Brewer C., Lingford-Hughes A., Myles J.S., Grasby P., Nutt D.J. Changes in regional cerebral blood flow elicited by craving memories in abstinent opiate-dependent subjects. Am J Psychiatry 2001, 158:1680-1686.
28. Daglish M.R., Weinstein A., Malizia A.L., Wilson S., Melichar J.K., Lingford-Hughes A., Myles J.S., Grasby P., Nutt D.J. Functional connectivity analysis of the neural circuits of opiate craving: 'more" rather than 'different'?. Neuroimage 2003, 20:1964-1970.
29. de Bruijn E.R., et al. Action monitoring in motor control: ERPs following selection. Psychophysiology 2003, 40:786-795.
30. Dehaene S., et al. Localization of a neural system for error detection and compensation. Psychol Sci 1994, 5:303-305.
31. Desmond J.E., et al. Increased frontocerebellar activation in alcoholics during verbal working memory: an fMRI study. Neuroimage 2003, 19:1510-1520.
32. Drevets W.C., Price J.C., Kupfer D.J., Kinahan P.E., Lopresti B., Holt D., Mathis C. PET measures of amphetamine-induced dopamine release in ventral versus dorsal striatum. Neuropsychopharmacology 1999, 21:694-709.
33. Due D.L., Huettel S.A., Hall W.G., Rubin D.C. Activation in mesolimbic and visuospatial neural circuits elicited by smoking cues: evidence from functional magnetic resonance imaging. Am J Psychiatry 2002, 159:954-960.
34. Duong T., Kim D.S., Kim S.G. Field dependence of the early negative and late positive BOLD response at 4.7 T and 9.4 T. Proceedings of the 8th Annual Meeting of ISMRM 2000, 994.
35. Eldreth D.A., et al. Abnormal brain activity in prefrontal brain regions in abstinent marijuana users. Neuroimage 2004, 23:914-920.
36. Ernst M., et al. Decision-making in a risk-taking task: a PET study. Neuropsychopharmacology 2002, 26:682-691.
37. Ernst M., et al. Decision-making in adolescents with behavior disorders and adults with substance abuse. Am J Psychiatry 2003, 160:33-40.
38. Fallgatter A.J., et al. Altered response control and anterior cingulate function in attention-deficit/hyperactivity disorder boys. Clin Neurophysiol 2004, 115:973-981.
39. Febo M., Segarra A.C., Nair G., Schmidt K., Duong T.Q., Ferris C.F. The neural consequences of repeated cocaine exposure revealed by functional MRI in awake rats. Neuropsychopharmacology 2005, 30:936-943.
40. Febo M., Segarra A.C., Tenney J.R., Brevard M.E., Duong T.Q., Ferris C.F. Imaging cocaine-induced changes in the mesocorticolimbic dopaminergic system of conscious rats. J Neurosci Methods 2004, 139(2):167-176.
41. Fillmore M.T., Rush C.R. Impaired inhibitory control of behavior in chronic cocaine users. Drug Alcohol Depend 2002, 66:265-273.
42. Fillmore M.T., Rush C.R., Marczinski C.A. Drug Alcohol Depend 2003, 71:143.
43. Finn P.R., et al. Early-onset alcoholism with conduct disorder: go/no go learning deficits, working memory capacity, and personality. Alcohol Clin Exp Res 2002, 26:186-206.
44. Forman S.D., et al. Opiate addicts lack error-dependent activation of rostral anterior cingulate. Biol Psychiatry 2004, 55:531-537.
45. Frankle W.G., Laruelle M. Neuroreceptor imaging in psychiatric disorders. Ann Nucl Med 2002, 16(7):437-446.
46. Garavan H., et al. Right hemispheric dominance of inhibitory control: an event-related fMRI study. Proc Natl Acad Sci USA 1999, 96:8301-8306.
47. Garavan H., Pankiewicz J., Bloom A., et al. Cue-induced cocaine craving: neuroanatomical specificity for drug users and drug stimuli. Am J Psychiatry 2000, 157(11):1789-1798.
48. Garavan H., et al. Dissociable executive functions in the dynamic control of behaviour: inhibition, error detection and correction. Neuroimage 2002, 17:1820-1829.
49. Gati J., Menon R.S., Ugurbil K., Rutt B.K. Experimental determination of the BOLD field strength dependence in vessels and tissues. Magn Reson Med 1997, 38:296-302.
50. Gilman S., Koeppe R.A., Adams K., et al. Positron emission tomographic studies of cerebral benzodiazepine-receptor binding in chronic alcoholics. Ann Neurol 1996, 40(2):163-171.
51. Goldstein R.Z., Volkow N.D. Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex. Am J Psychiatry 2002, 159:1642-1652.
52. Goldstein R.Z., et al. Addiction changes orbitofrontal gyrus function: involvement in response inhibition. NeuroReport 2001, 12:2595-2599.
53. Grant S., London E.D., Newlin D.B., et al. Activation of memory circuits during cue-elicited cocaine craving. Proc Natl Acad Sci USA 1996, 93:12040-12045.
54. Grant S., et al. Drug abusers show impaired performance in a laboratory test of decision making. Neuropsychologia 2000, 38:1180-1187.
55. Greenwald M.K., Johanson C.E., Moody D.E., Woods J.H., Kilbourn M.R., Koeppe R.A., Schuster C.R., Zubieta J.K. Effects of buprenorphine maintenance dose on mu-opioid receptor availability, plasma concentrations, and antagonist blockade in heroin-dependent volunteers. Neuropsychopharmacology 2003, 28:2000-2009.
56. 13C] glucose. J Neurochem 1994, 63:1377-1385.
57. Grusser S.M., Wrase J., Klein S., Hermann D., Smolka M.N., Ruf M., Weber-Fahr W., Flor H., Mann K., Braus D.F., Heinz A. Cue-induced activation of the striatum and medial prefrontal cortex is associated with subsequent relapse in abstinent alcoholics. Psychopharmacology (Berl) 2004, 175:296-302.
58. Heinz A., Ragan P., Jones D.W., Hommer D., Williams W., Knable M.B., Gorey J.G., Doty L., Geyer C., Lee K.S., Coppola R., Weinberger D.R., Linnoila M. Reduced central serotonin transporters in alcoholism. Am J Psychiatry 1998, 155:1544-1549.
59. Heinz A., Jones D.W., Mazzanti C., et al. A relationship between serotonin transporter genotype and in vivo protein expression and alcohol neurotoxicity. Biol Psychiatry 2000, 47(7):643-649.
60. Hester R., Garavan H. Executive dysfunction in cocaine addiction: Evidence for discordant frontal, cingulate and cerebellar activity. J Neuroscience 2004, 24:11017-11022.
61. Hester R., Fassbender C., Garavan H. Individual differences in error processing: a review and meta-analysis of three event-related fMRI studies using the GO/NOGO task. Cereb Cortex 2004, 14(9):966-973.
62. Hester R., et al. Beyond common resources: the cortical basis for resolving task interference. Neuroimage 2004, 23:202-212.
63. Hester R., Garavan H. Neural correlates of error detection with and without awareness. Memory and Cognition 2005, 33:221-223.
64. Holroyd C.B., Coles M.G.H. The neural basis of human error processing: reinforcement learning, dopamine, and the error-related negativity. Psychol Rev 2002, 109:679-709.
65. Hu X., Yacoub E., Andersen P., Vaughan T., Adriany G., Merkle H., Ugurbil K. Initial experience with fMRI in humans at 7 Tesla. Proceedings of the 8th Annual Meeting of ISMRM 2000, 935.
66. Hyder F., Chase J.R., Behar K.L., Mason G.F., Siddeek M., Rothman D.L., Shulman R.G. Increased tricarboxylic acid cycle flux in rat brain during forepaw stimulation. Proc Natl Acad Sci USA 1996, 93:7612-7617.
67. Ireland M.D., Lowe A.S., Reavill C., James M.F., Leslie R.A., Williams S.C. Mapping the effects of the selective dopamine d2/d3 receptor agonist quinelorane using pharmacological MRI. Neuroscience 2005, 133:315-326.
68. Kaufman, J.N. and Garavan, H. Acute effects of cocaine on the functional neuroanatomy of cognitive control (11.2, Nov).
69. Kaufman J.N., et al. Cingulate hypoactivity in cocaine users during a GO/NOGO task as revealed by event-related fMRI. J Neuroscience 2003, 23:7839-7843.
70. Kerns J.G., et al. Anterior cingulate conflict monitoring and adjustments in control. Science 2004, 303:1023-1026.
71. Khantzian E.J. The self-medication hypothesis of substance abuse disorders: a reconsideration and recent applications. Harv Rev Psychiatry 1997, 4:231-244.
72. Kling M.A., Carson R.E., Borg L., Zametkin A., Matochik J.A., Schluger J., Herscovitch P., Rice K.C., Ho A., Eckelman W.C., Kreek M.J. Opioid receptor imaging with positron emission tomography and [(18)F]cyclofoxy in long-term, methadone-treated former heroin addicts. J Pharmacol Exp Ther 2000, 295:1070-1076.
73. Koob G.F., Le Moal M. Drug abuse: hedonistic homeostatic dysregulation. Science 1997, 278:52-58.
74. Kubler A., Murphy K., Garavan H. Effects of cocaine use on attentional control within and between verbal and visuospatial working memory. Eur J Neurosci 2005, 21:1984-1992.
75. Laruelle M., Abi-Dargham A., van Dyck C.H., Rosenblatt W., Zea-Ponce Y., Zoghbi S.S., Baldwin R.M., Charney D.S., Hoffer P.B., Kung H.F., et al. SPECT imaging of striatal dopamine release after amphetamine challenge. J Nucl Med 1995, 36:1182-1190.
76. Lee S., Silva A.C., Urgurbil K., Kim S.G. Diffusion weighted spin-echo fMRI at 9.4T: microvascular/tissue contribution to BOLD signal changes. Magn Reson Med 1999, 42(5):919-928.
77. Lingford-Hughes A.R., Acton P.D., Gacinovic S., et al. Reduced levels of GABA-benzodiazepine receptor in alcohol dependency in the absence of grey matter atrophy. Br J Psychiatry 1998, 173:116-122.
78. Lingford-Hughes A., Hume S.P., Feeney A., Hirani E., Osman S., Cunningham V.J., Pike V.W., Brooks D.J., Nutt D.J. Imaging the GABA-benzodiazepine receptor subtype containing the alpha5-subunit in vivo with [11C]Ro 15 4513 positron emission tomography. J Cereb Blood Flow Metab 2002, 22:878-889.
79. Liu X., et al. Smaller volume of prefrontal lobe in polysubstance abusers: a magnetic resonance imaging study. Neuropsychopharmacology 1998, 18:243-252.
80. London E.D., Ernst M., Glant S., Bonson K., Weinstein A. Orbitofrontal cortex and human drug abuse: functional imaging. Cereb Cortex 2000, 10:334-342.
81. Lowe A.S., Williams S.C., Symms M.R., Stolerman I.P., Shoaib M. Functional magnetic resonance neuroimaging of drug dependence: naloxone-precipitated morphine withdrawal. Neuroimage 2002, 17(2):902-910.
82. Lyvers M., Yakimoff M. Neuropsychological correlates of opiod dependence and withdrawal. Addict Behav 2003, 28:605-611.
83. Martinez D., Broft A., Foltin R.W., Slifstein M., Hwang D.R., Huang Y., Perez A., Frankle W.G., Cooper T., Kleber H.D., Fischman M.W., Laruelle M., Frankle W.G. Cocaine dependence and d2 receptor availability in the functional subdivisions of the striatum: relationship with cocaine-seeking behavior. Neuropsychopharmacology 2004, 29(6):1190-1202.
84. Matochik J.A., et al. Fontal cortical tissue composition in abstinent cocaine abusers: a magnetic resonance imaging study. Neuroimage 2003, 19:1095-1102.
85. Mazas C.A., et al. Decision-making biases, antisocial personality, and early-onset alcoholism. Alcohol: Clin Exp Res 2000, 24:1036-1040.
86. McCann U.D., Szabo Z., Scheffel U., Dannals R.F., Ricaurte G.A. Positron emission tomographic evidence of toxic effect of MDMA ('Ecstasy') on brain serotonin neurons in human beings. Lancet 1998, 352:1433-1437.
87. 11C]WIN-35,428. J Neurosci 1998, 18(20):8417-8422.
88. 11C]-diprenorphine to image opioid receptor occupancy by methadone in opioid addiction: clinical and preclinical studies. J Pharmacol Exp Ther. 2004, doi: 10. 1124/pet.104.072686.
89. Menon R., Goodyear B.G. Submillimeter functional localization in human striate cortex using BOLD contrast at 4 Tesla: implications for the vascular point-spread function. Magn Reson Med 1999, 41(2):230-235.
90. Monterosso J., et al. Three decision-making tasks in cocaine-dependent patients: do they measure the same construct?. Addiction 2001, 96:1825-1837.
91. Moris P., Bachelard H. Reflections on the application of 13C-MRS to research on brain metabolism. NMR Biomed 2003, 16:303-312.
92. Morgan D., Grant K.A., Gage H.D., Mach R.H., Kaplan J.R., Prioleau O., Nader S.H., Buchheimer N., Ehrenkaufer R.L., Nader M.A. Social dominance in monkeys: dopamine D2 receptors and cocaine self-administration. Nat Neurosci 2002, 5(2):169-174.
93. 129Xe gas: preliminary human results. Magn Reson Med 1997, 37:809-815.
94. Myrick H., Anton R.F., Li X, Henderson S., Drobes D., Voronin K., George M.S. Differential brain activity in alcoholics and social drinkers to alcohol cues: relationship to craving. Neuropsychopharmacology 2004, 29:393-402.
95. Navon G., Song Y.Q., Room T., Appelt S., Taylor R.E., Pines A. Enhancement of solution NMR and MRI with laser-polarized xenon. Science 1996, 271:1848-1851.
96. Peoples L.L. Will, anterior cingulate cortex, and addiction. Science 2002, 296:1623-1624.
97. th Ann. Meeting Int. Soc. Magn. Reson. Med. 2004, 690.
98. Petry N., et al. Shortened time horizons and insensitivity to future consequences in heroin addicts. Addiction 1998, 93:729-738.
99. Pietrass T., Gaede H.C., Bifone A., Pines A., Ripmeester J.A. Monitoring xenon clathrate hydrate formation on ice surfaces with optically enhanced Xe-129 NMR. J Am Chem Soc 1995, 117:7520-7525. 28.
100. Reneman L., Booij J., de Bruin K., Reitsma J.B., de Wolff F.A., Gunning W.B., Den Heeten G.J., Van Den B.W. Effects of dose, sex, and long-term abstention from use on toxic effect of MDMA (ecstasy) on brain serotonin neurons. Lancet 2001, 358:1864-1869.
101. Repo E., Kuikka J.T., Bergstrom K.A., Karhu J., Hiltunen J., Tiihonen J. Dopamine transporter and D2-receptor density in late-onset alcoholism. Psychopharmacology (Berl) 1999, 147:314-318.
102. Ridderinkhof K.R., et al. Alcohol consumption impairs detection of performance errors in mediofrontal cortex. Science 2003, 298:2209-2211.
103. Rose J.E., Behm F.M., Westman E.C., Mathew R.J., London E.D., Hawk T.C., Turkington T.G., Coleman R.E. PET studies of the influences of nicotine on neural systems in cigarette smokers. Am J Psychiatry 2003, 160:323-333.
104. Rushworth M.F.S., et al. Action sets and decisions in the medial frontal cortex. Trends Cog Sci 2004, 8:410-417.
105. Ruth U., Hof T., Schmidt J., Fick D., Jansch H.J. Production of nitrogen-free, hyperpolarized Xe-129 gas. Appl Phys B-Lasers and Optics 1999, 68(1):93-97.
106. Scheres A., Oosterlaan J., Swanson J., Morein-Zamir S., Meiran N., Schut H., Vlasveld L., Sergent J.A. Ab Child Psychol 2003, 31:105.
107. 11C] raclopride at dopamine receptors in human subjects. Am J Psychiatry 1997, 154(9):1209-1213.
108. Schultz W. Dopamine neurons and their role in reward mechanisms. Current Op Neurobiol 1997, 7:191-197.
109. Schultz W., et al. A neural substrate of prediction and reward. Science 1997, 275:1593-1599.
110. Sell L.A., Morris J., Bearn J., Fackowiak R.S., Friston K.J., Dolan R.J. Activation of reward circuitry in human opiate addicts. Eur J Neurosci 1999, 11:1042-1048.
111. Sell L.A., Morris J.S., Bearn J., Frackowiak R.S., Friston K.J., Dolan R.J. Neural responses associated with cue-evoked emotional states and heroin in opiate addicts. Drug Alcohol Depend 2000, 60:207-216.
112. Semple D.M., Ebmeier K.P., Glabus M.F., O'Carroll R.E., Johnstone E.C. Reduced in vivo binding to the serotonin transporter in the cerebral cortex of MDMA ('ecstasy') users. Br J Psychiatry 1999, 175:63-69.
113. Shoaib M., Lowe A.S., Williams S.C. Imaging localised dynamic changes in the nucleus accumbens following nicotine with drawal in rats. Neuroimage 2004, 22(2):847-854.
114. Sibson N.R., Dhankhar A., Mason G.F., Rothman D., Behar K.L., Shulman R.G. Stoichiometric coupling of brain glucose metabolism and glutamatergic neuronal activity. Proc Natl Acad Sci USA 1998, 95:316-321.
115. Stapleton J.M., et al. Cerebral glucose utilization in polysubstance abuse. Neuropsychopharmacology 1995, 13:21-31.
116. Stoltz E., Villard B., Meyerhoff M., Nacher P.J. Polarization analysis of the light emitted by an optically pumped He-3 gas. Appl Phys B-Lasers and Optics 1996, 63(6):635-640.
117. Stout J.C., Rock S.L., Campbell M.C., Busemeyer J.R., Finn P.R. Psychological processes underlying risky decisions in drug abusers. Psychol Addict Behav 2005, 19:148-157.
118. Tarter R.E., et al. Neurobehavioral disinhibition in childhood predicts early age at onset of substance use disorder. Am J Psychiatry 2003, 160:1078-1085.
119. Thomasius R., Petersen K., Buchert R., Andresen B., Zapletalova P., Wartberg L., Nebeling B., Schmoldt A. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users. Psychopharmacology (Berl) 2003, 167:85-96.
120. Tiihonen J., Kuikka J., Bergstrom K., et al. Altered striatal dopamine re-uptake site densities in habitually violent and non-violent alcoholics. Nat Med 1995, 1(7):654-657.
121. Volkow N.D., Fowler J.S. Addiction, a disease of compulsion and drive: involvement of the orbitofrontal cortex. Cereb Cortex 2000, 10:318-325.
122. Volkow N.D., et al. Long-term frontal brain metabolic changes in cocaine abusers. Synapse 1992, 11:184-190.
123. Volkow N.D., Fowler J.S., Wang G.J., Hitzemann R., Logan J., Schyler D.J., Dewey S.L., Wolf A.P. Increased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine users. Synapse 1993, 14:169-177.
124. Volkow N.D., Wang G.J., Gatley S.J., Fowler J.S., Ding Y.S., Logan J., Hitzemann R., Angrist B., Lieberman J. Temporal relationships between the pharmacokinetics of methylphenidate in the human brain and its behavioral and cardiovascular effects. Psychopharmacology (Berl) 1996, 123:26-33.
125. Volkow N.D., Wang G.J., Fowler J.S., Gatley S.J., Ding Y.S., Logan J., Dewey S.L., Hitzemann R., Lieberman J. Relationship between psychostimulant induced high and dopamine transporter occupancy. Proc Natl Acad Sci USA 1996, 93:10388-10392.
126. Volkow N.D., Wang G.J., Fowler J.S., et al. Decreases in dopamine receptors but not in dopamine transporters in alcoholics. Alcohol Clin Exp Res 1996, 20(9):1594-1598.
127. Volkow N.D., Wang G.J., Fischman M.W., et al. Relationship between subjective effects of cocaine and dopamine transporter occupancy. Nature (Lond) 1997, 386:827-830.
128. Volkow N.D., Wang G.J., Fowler J.S., Logan J., Gatley S.J., Hitzemann R., Chen A.D., Dewey S.L., Pappas N. Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects. Nature 1997, 386:830-833.
129. Volkow N.D., Wang G.J., Fowler J.S., Logan J., Gatley S.J., Gifford A., Hitzemann R., Ding Y.S., Pappas N. Prediction of reinforcing responses to psychostimulants in humans by brain dopamine D2 receptor levels. Am J Psychiatry 1999, 156:1440-1443.
130. Volkow N.D., et al. Imaging studies on the role of dopamine in cocaine reinforcement and addiction in humans. J Psychopharmacology 1999, 13:337-345.
131. Volkow N.D., Fowler J.S., Wang G.J., Goldstein R.Z. Role of dopamine, the frontal cortex and memory circuits in drug addiction: insight from imaging studies. Neurobiol Learn Mem 2002, 78:610-624.
132. Volkow N.D., Wang G.J., Fowler J.S., Thanos P.P., Logan J., Gatley S.J., Gifford A., Ding Y.S., Wong C., Pappas N., Thanos P. Brain DA D2 receptors predict reinforcing effects of stimulants in humans: replication study. Synapse 2002, 46:79-82.
133. Volkow N.D., Wang G.J., Ma Y., Fowler J.S., Zhu W., Maynard L., Telang F., Vaska P., Ding Y.S., Wong C., Swanson J.M. Expectation enhances the regional brain metabolic and the reinforcing effects of stimulants in cocaine abusers. J Neurosci 2003, 23:11461-11468.
134. Volkow N.D., Fowler J.S., Wang G.J. The addicted human brain viewed in the light of imaging studies: brain circuits and treatment strategies. Neuropharmacology 2004, 47:3-13.
135. Waters A.J., et al. Attentional bias predicts outcome in smoking cessation. Health 2003, 22:378-387.
136. Wexler B.E., Gottschalk C.H., Fulbright R.K., et al. Functional magnetic resonance imaging of cocaine craving. Am J Psychiatry 2001, 158(1):86-95.
137. Whitlow C., et al. Long-term heavy marijuana users make costly decisions on a gambling task. Drug Alcohol Depend 2004, 76:107-111.
138. Whitlow, C., et al. (in press) Long-term heavy marijuana users choose high immediate gains despite higher future losses on a decision-making task. Psychopharmacology.
139. Wilson S.J., Sayette M.A., Fiez J.A. Prefrontal responses to drug cues: a neurocognitive analysis. Nat Neurosci 2004, 7:211-214.
140. Wise R.A., Rompre P.P. Brain dopamine and reward. Ann Rev Psychology 1989, 40:191-225.
141. Xi Z.X., Wu G., Stein E.A., Li S.J. Opiate tolerance by heroin self-administration: an fMRI study in rat. Magn Reson Med 2004, 52(1):108-114.
142. Xu H., Li S.J., Bodurka J., Zhao X., Xi Z.X., Stein EA, Xu H., Li S.J., Bodurka J., Zhao X., Xi Z.X., Stein E.A. Neuroreport 2000, 11(5):1085-1092.
143. Yechiam E., et al. Individual differences in the response to forgone payoffs: an examination of high functioning drug abusers. J Behav Decision Making 2005, 18:97-110.
144. Zubieta J.K., Gorelick D.A., Stauffer R., Ravert H.T., Dannals R.F., Frost J.J. Increased mu opioid receptor binding detected by PET in cocaine-dependent men is associated with cocaine craving. Nat Med 1996, 2:1225-1229.